BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 140 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333,468 | -41.2% | 47,100 | -41.6% | 0.00% | -40.0% |
| Q2 2023 | $567,424 | +333.4% | 80,600 | +413.4% | 0.01% | +400.0% |
| Q1 2023 | $130,938 | +1.8% | 15,700 | +40.2% | 0.00% | 0.0% |
| Q4 2022 | $128,576 | +64.8% | 11,200 | +6.7% | 0.00% | 0.0% |
| Q4 2020 | $78,000 | +116.7% | 10,500 | 0.0% | 0.00% | – |
| Q3 2020 | $36,000 | -49.3% | 10,500 | -29.5% | 0.00% | -100.0% |
| Q2 2020 | $71,000 | +22.4% | 14,900 | -11.8% | 0.00% | 0.0% |
| Q4 2019 | $58,000 | – | 16,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |